NR 507 Advanced
Pathophysiology: 50 Essential
Questions & Answers Mastery
Guide for Board & Certification
Success
Section 1: Cellular & Genetic Foundations
Q1: A patient with a known history of chronic hepatitis C presents
with jaundice and ascites. Liver biopsy reveals extensive bridging
fibrosis and the formation of regenerative nodules. What is the
most likely cellular mechanism driving this condition?
A1: The most likely condition is cirrhosis, driven by chronic
inflammation leading to hepatocellular necrosis, followed by
aberrant tissue repair. This involves activation of hepatic stellate cells,
which transform into myofibroblasts and deposit excessive extracellular
matrix (collagen), causing fibrosis and distorting liver architecture.
Q2: A 65-year-old male is diagnosed with metastatic prostate
cancer. Biopsy reveals cells with a high nuclear-to-cytoplasmic ratio
and prominent nucleoli. What is the clinical significance of "grade"
versus "stage" in this patient?
A2:
• Grade describes the tumor's aggressiveness (differentiation) and
predicts growth rate.
, • Stage describes the tumor's extent and spread (TNM system) and
predicts prognosis and guides treatment. A high-grade tumor
confined to the prostate (low stage) may be curable; a low-grade
tumor that has metastasized (high stage) is not curable but
manageable.
Q3: What is the difference between necrosis and apoptosis at the
cellular level?
A3:
• Necrosis: An unregulated, pathologic cell death caused by injury
(ischemia, toxins). It involves cell swelling, membrane rupture,
inflammation, and spillage of cellular contents into the surrounding
tissue.
• Apoptosis: A regulated, programmed cell death (physiologic or
pathologic). It involves cell shrinkage, chromatin condensation,
membrane blebbing, and formation of apoptotic bodies that are
phagocytosed without triggering inflammation.
Q4: A patient with sickle cell disease experiences a vaso-occlusive
crisis. What is the molecular basis of this disorder?
A4: A single point mutation in the beta-globin gene (glutamic acid →
valine at position 6) causes hemoglobin S (HbS). Under hypoxic
conditions, HbS polymerizes, forming rigid, sickle-shaped red blood cells.
These cells obstruct microcirculation, causing ischemia, pain, and
infarction.
Q5: What is the difference between a proto-oncogene and a tumor
suppressor gene?
, A5:
• Proto-oncogene: A normal gene that promotes cell growth and
division. When mutated or overexpressed, it becomes
an oncogene that drives uncontrolled proliferation (e.g., RAS,
MYC). It acts in a dominant manner (one copy is enough).
• Tumor Suppressor Gene: A normal gene that inhibits cell growth
and repairs DNA. When both copies are inactivated (loss of
function), it removes the "brakes" on cell division (e.g., p53, RB1). It
acts in a recessive manner (both copies must be lost).
Q6: What are the cardinal signs of inflammation and what are their
underlying pathophysiological mechanisms?
A6: The five cardinal signs are:
1. Redness (Rubor): Vasodilation (increased blood flow) mediated by
histamine and nitric oxide.
2. Heat (Calor): Increased blood flow and increased metabolic
activity.
3. Swelling (Tumor): Increased vascular permeability leading to
exudation of fluid into the interstitial space.
4. Pain (Dolor): Direct nerve compression by swelling and the action
of inflammatory mediators (bradykinin, prostaglandins).
5. Loss of Function (Functio Laesa): Tissue damage, pain, and
swelling limiting mobility.
Q7: A patient is diagnosed with Familial Hypercholesterolemia.
What is the genetic basis for this condition?
A7: This is an autosomal dominant disorder caused by a mutation in the
gene encoding the LDL receptor. This results in defective or absent LDL
receptors on hepatocytes, impairing the clearance of LDL cholesterol
Pathophysiology: 50 Essential
Questions & Answers Mastery
Guide for Board & Certification
Success
Section 1: Cellular & Genetic Foundations
Q1: A patient with a known history of chronic hepatitis C presents
with jaundice and ascites. Liver biopsy reveals extensive bridging
fibrosis and the formation of regenerative nodules. What is the
most likely cellular mechanism driving this condition?
A1: The most likely condition is cirrhosis, driven by chronic
inflammation leading to hepatocellular necrosis, followed by
aberrant tissue repair. This involves activation of hepatic stellate cells,
which transform into myofibroblasts and deposit excessive extracellular
matrix (collagen), causing fibrosis and distorting liver architecture.
Q2: A 65-year-old male is diagnosed with metastatic prostate
cancer. Biopsy reveals cells with a high nuclear-to-cytoplasmic ratio
and prominent nucleoli. What is the clinical significance of "grade"
versus "stage" in this patient?
A2:
• Grade describes the tumor's aggressiveness (differentiation) and
predicts growth rate.
, • Stage describes the tumor's extent and spread (TNM system) and
predicts prognosis and guides treatment. A high-grade tumor
confined to the prostate (low stage) may be curable; a low-grade
tumor that has metastasized (high stage) is not curable but
manageable.
Q3: What is the difference between necrosis and apoptosis at the
cellular level?
A3:
• Necrosis: An unregulated, pathologic cell death caused by injury
(ischemia, toxins). It involves cell swelling, membrane rupture,
inflammation, and spillage of cellular contents into the surrounding
tissue.
• Apoptosis: A regulated, programmed cell death (physiologic or
pathologic). It involves cell shrinkage, chromatin condensation,
membrane blebbing, and formation of apoptotic bodies that are
phagocytosed without triggering inflammation.
Q4: A patient with sickle cell disease experiences a vaso-occlusive
crisis. What is the molecular basis of this disorder?
A4: A single point mutation in the beta-globin gene (glutamic acid →
valine at position 6) causes hemoglobin S (HbS). Under hypoxic
conditions, HbS polymerizes, forming rigid, sickle-shaped red blood cells.
These cells obstruct microcirculation, causing ischemia, pain, and
infarction.
Q5: What is the difference between a proto-oncogene and a tumor
suppressor gene?
, A5:
• Proto-oncogene: A normal gene that promotes cell growth and
division. When mutated or overexpressed, it becomes
an oncogene that drives uncontrolled proliferation (e.g., RAS,
MYC). It acts in a dominant manner (one copy is enough).
• Tumor Suppressor Gene: A normal gene that inhibits cell growth
and repairs DNA. When both copies are inactivated (loss of
function), it removes the "brakes" on cell division (e.g., p53, RB1). It
acts in a recessive manner (both copies must be lost).
Q6: What are the cardinal signs of inflammation and what are their
underlying pathophysiological mechanisms?
A6: The five cardinal signs are:
1. Redness (Rubor): Vasodilation (increased blood flow) mediated by
histamine and nitric oxide.
2. Heat (Calor): Increased blood flow and increased metabolic
activity.
3. Swelling (Tumor): Increased vascular permeability leading to
exudation of fluid into the interstitial space.
4. Pain (Dolor): Direct nerve compression by swelling and the action
of inflammatory mediators (bradykinin, prostaglandins).
5. Loss of Function (Functio Laesa): Tissue damage, pain, and
swelling limiting mobility.
Q7: A patient is diagnosed with Familial Hypercholesterolemia.
What is the genetic basis for this condition?
A7: This is an autosomal dominant disorder caused by a mutation in the
gene encoding the LDL receptor. This results in defective or absent LDL
receptors on hepatocytes, impairing the clearance of LDL cholesterol
